Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis–Related Interstitial Lung Disease (Scleroderma Lung Study <scp>III</scp> ): An Investigator‐Initiated, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 TrialDinesh Khanna, Marcin A. Trojanowski, Gary M. Hunninghake et al.|ACR Open Rheumatology|2025Cited by 3